Method for preparing hydroxylamine derivatives

By introducing the hydroxamic acid group early in the reaction sequence and using palladium catalysts, the method significantly reduces carboxylic acid by-products, improving the efficiency and simplifying the purification of hydroxamic acid antibiotics.

JP2024545294APending Publication Date: 2024-12-05INTERVET INT BV
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
JP2024537411
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-12-24
Filing Date
2022-12-23
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Existing methods for producing hydroxamic acid antibiotics result in significant formation of undesirable carboxylic acid by-products, necessitating tedious purification processes to isolate the desired product.

Method used

A method is developed where the hydroxamic acid group is introduced early in the reaction sequence, utilizing palladium catalysts and specific reaction conditions to reduce carboxylic acid by-products to less than 2%, allowing for facile separation through selective crystallization.

Benefits of technology

The method effectively minimizes carboxylic acid by-products to less than 2%, simplifying the purification process and enhancing the efficiency of hydroxamic acid derivative production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024545294000001_ABST
    Figure 2024545294000001_ABST
Patent Text Reader

Abstract

A process for preparing a compound of formula (I) or a salt thereof with reduced formation of a carboxylic acid by-product. [Formula 1] TIFF2024545294000126.tif31130
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] An improved method for preparing compounds that are hydroxylamine derivatives. [Background technology]

[0002] Hydroxamic acid antibiotics are small molecule inhibitors of the enzyme responsible for lipid A biosynthesis in Gram-negative bacteria (see Kalinin DV, Holl R. Expert Opin Ther Pat. 2017 Nov;27(11):1227-1250. doi:10.1080 / 13543776.2017.1360282. Epub 2017 Aug 4. PMID:28742403).

[0003] WO 2018 / 115432 discloses compounds that are hydroxamic acid antibiotics, useful for the treatment of animal respiratory diseases, in particular bovine or porcine respiratory disease (BRD and SRD). Examples 1Q, 1R and 1S disclose processes for making these compounds, in which the hydroxamic acid group is formed in the last or penultimate step of the synthesis.

[0004] EP 3750881 discloses antibiotic compounds and their preparations that exhibit excellent antibacterial activity, especially against gram bacteria. Specifically, the conversion of ester intermediates to the corresponding hydroxamic acid end products is disclosed.

[0005] Mohammad A. Alam, "Methods for Hydroxamic Acid Synthesis," Curr Org Chem. 2019;23(9):978-993, discloses methods for producing hydroxamic acid compounds from ester and carboxylic acid precursors.

[0006] Fei, et al., A, Org. Process Res. Dev. 2012, 16, 1436-1441, discloses a synthetic route for producing hydroxamic acid compounds, in which the hydroxamic acid group is introduced in the final step.

[0007] Ho et al., J. Org. Chem. 2005, 70, 4873-4875, disclose that the addition of small amounts of solid KCN to solutions in THF / MeOH / 50% NH2OH aqueous solution and to solid-phase esters increases the efficiency of their conversion to the corresponding hydroxamic acids. It is also disclosed that the analogous carboxylic acids are formed as by-products (see Table 1).

[0008] Park et al., Eur. J. Org. Chem. 2013, 1973-1978, discloses the synthesis of aryl alkyne carboxylic acids from aryl bromides and alkyne carboxylic acids using palladium catalysis, specifically Pd(PPh3)4.

[0009] DeVasher et al., J. Org. Chem., Vol. 69, No. 23, 2004, pp 7919-7927, discloses the palladium-catalyzed Sonogashira coupling of aryl bromides with phenyl alkynes. This reference does not disclose the Sonogashira coupling of aryl bromides bearing hydroxamic acid substituents.

[0010] However, there is no disclosure of the preparation of aryl alkyne hydroxamates from aryl bromides and aryl alkynes bearing hydroxamic acid substituents using a Pd(PPh3)4 catalyst.

[0011] There is a need for methods for producing hydroxamic acid antibiotics that reduce the formation of the corresponding carboxylic acid by-product. [Prior art documents] [Patent documents]

[0012] [Patent Document 1] International Publication No. 2018 / 115432 [Patent Document 2] European Patent No. 3750881 [Non-patent literature]

[0013] [Non-Patent Document 1] Kalinin DV, Holl R.Expert Opin Ther Pat.2017 Nov;27(11):1227-1250.doi:10.1080 / 13543776.2017.1360282.Epub 2017 Aug 4.PMID:28742403 [Non-Patent Document 2] Mohammad A.Alam, “Methods for Hydroxamic Acid Synthesis”, Curr Org Chem.2019;23(9):978-993 [Non-Patent Document 3] Fei,et al.,A,Org.PROCESS Res.Dev.2012, 16, 1436-1441 [Non-Patent Document 4] Ho et al., J.Org.Chem.2005, 70, 4873-4875 [Non-Patent Document 5] Park et al.Eur.J.Org.Chem.2013, 1973-1978 [Non-Patent Document 6] DeVasher et al., J.Org.Chem., Vol.69, No.23, 2004, pp7919-7927 Summary of the Invention

[0014] The present invention relates to a compound of formula (I) [ka] or a salt thereof, comprising the steps of: Compound of formula (III) [ka] with a compound of formula (IV) [ka] and converting the compound of formula (IV) into a compound of formula (IX) [ka] or a salt thereof, to produce less than 2% of a compound of formula (XI) as a by-product. [ka] obtaining a compound of formula (I) comprising During the ceremony, R 1 and R 2 are each independently hydrogen or C1-C4 alkyl; R 3 is NH2 or OH, R 4 is NH2 or CH2-NH-R 5 and R 5 is hydrogen, cyclopropyl, or -CH2- substituted with -CH2OCH3, -CHF2, -CF3, 3-pyridinyl or 4-pyridinyl, R 6 is -NHC(O)OC(CH3)3 or -OC(CH3)3. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0015] Hydroxamic acid antibiotics are often produced by introducing a hydroxamic acid group into the corresponding ester in one of the final reaction steps. These processes for producing hydroxamic acid derivatives often produce the corresponding carboxylic acid as a by-product. Further laborious purification of the desired hydroxamic acid is required to remove the undesired carboxylic acid. The claimed invention is a process for producing hydroxamic acid derivatives with significantly reduced production of the undesired carboxylic acid by-product.

[0016] Formation of the hydroxamic acid in the final step allowed the isolation of the desired product in the presence of 3-8% carboxylic acid.

[0017] Scheme C1 [ka]

[0018] See Comparative Example 1 below.

[0019] Attempted formation of the hydroxamic acid on the Boc-protected intermediate also led to large amounts of the carboxylic acid by-product (14-20%).

[0020] Scheme C2 [ka]

[0021] See Comparative Example 2 below.

[0022] Introducing the hydroxamic acid early in the sequence of reaction steps reduces the amount of carboxylic acid produced along with the final product and allows for easier purification by selective crystallization.

[0023] In contrast to the comparative examples, the claimed process reproducibly yields less than 2% carboxylic acid and allows for easy separation of this by-product by selective crystallization of the desired hydroxamic acid derivative. Scheme 1 shows the overall process of the invention with the introduction of the hydroxamate group in the second step of the reaction sequence.

[0024] Scheme 1 [ka]

[0025] Scheme 2 shows the complete process when R4 is a cyclopropylamine.

[0026] Scheme 2 [ka]

[0027] In one embodiment of the present invention, the method for preparing a compound of formula (I) comprises the step of reacting a compound of formula (III) [ka] with hydroxylamine in the presence of lithium hydroxide to give a compound of formula (IV) [ka] The method includes the step of generating

[0028] In one embodiment of the present invention, the process for preparing a compound of formula (I) comprises the step of reacting a compound of formula (IV) [ka] with a compound of formula (IX) [ka] or its salt Coupling in the presence of a palladium catalyst, a base and optionally copper iodide to give a compound of formula (X) [ka] and then reacting the compound of formula (X) with to a compound of formula (I) or a salt thereof.

[0029] In one embodiment of the present invention, the method for preparing a compound of formula (I) comprises the step of reacting a compound of formula (II) [ka] with 4 bromobenzoic acid to obtain a compound of formula (III).

[0030] In one embodiment of the present invention, the process for preparing a compound of formula (I) comprises the steps of: a) A compound of formula (II) [ka] with 4-bromobenzoic acid to give a compound of formula (III) [ka] obtaining b) reacting a compound of formula (III) with hydroxylamine in the presence of lithium hydroxide to give a compound of formula (IV) [ka] generating c) reacting a compound of formula (IV) with a compound of formula (IX) [ka] or its salt Reacting in the presence of a palladium catalyst, a base and optionally copper iodide to give a compound of formula (X) [ka] and d) reacting the compound of formula (X) with an acid to obtain a compound of formula (I) or a salt thereof, During the ceremony, R 1 and R 2 are each independently hydrogen or C1-C4 alkyl; R 3 is NH2 or OH, R 4 is NH2 or CH2-NH-R 5 and R 5 is hydrogen, cyclopropyl, or -CH2- substituted with -CH2OCH3, -CHF2, -CF3, 3-pyridinyl or 4-pyridinyl, and R 6is -NHC(O)OC(CH3)3 or -OC(CH3)3.

[0031] In one embodiment of the present invention, the palladium catalyst is a zero-valent palladium catalyst. In one embodiment, the palladium catalyst is Pd2(dba)3; Pd(tBu3P)2; Pd(Cy3P)2 or Pd(PPh3)4, preferably Pd(PPh3)4.

[0032] In one embodiment of the present invention, the palladium catalyst is Pd(PPh3)4.

[0033] In one embodiment of the invention, the compound of formula I is selected from the group consisting of: [Table 1]

[0034] In one embodiment of the invention, the compound of formula (I) is a hydrobromide salt, a dihydrobromide salt, a hydrochloride salt or a dihydrochloride salt.

[0035] Another embodiment of the present invention is a compound of formula (X) [ka] or a salt thereof, During the ceremony, R 1 and R 2 are each independently hydrogen or C1-C4 alkyl optionally substituted with NH2 or OH, R 4 is NH2 or CH2-NH-R 5 and R 5 is hydrogen, cyclopropyl, or -CH2OCH3, -CHF2, -CF3, or -CH2- substituted with pyridine, and R 6 is -NHC(O)OC(CH3)3 or -OC(CH3)3.

[0036] In one embodiment of the invention, the compound of formula X is selected from the group consisting of: [Table 2]

[0037] In one embodiment of the invention, the compound is a hydrobromide salt, a dihydrobromide salt, a hydrochloride salt or a dihydrochloride salt.

[0038] Another embodiment of the present invention is a compound of formula (X) [ka] or a salt thereof, Compound of formula (IX) [ka] with a compound of formula (IV) [ka] in the presence of a palladium catalyst, a base and optionally copper iodide to obtain a compound of formula (X) and optionally converting it into a salt, During the ceremony, R 1 and R 2 are each independently hydrogen or C1-C4 alkyl optionally substituted with NH2 or OH, R 4 is NH2 or CH2-NH-R 5 and R 5 is hydrogen, cyclopropyl, or -CH2- substituted with -CH2OCH3, -CHF2, -CF3, 3-pyridinyl or 4-pyridinyl, and R 6 is -NHC(O)OC(CH3)3 or -OC(CH3)3.

[0039] In one embodiment of the present invention, the palladium catalyst is a zero-valent palladium catalyst. In one embodiment, the palladium catalyst is Pd2(dba)3; Pd(tBu3P)2; Pd(Cy3P)2 or Pd(PPh3)4, preferably Pd(PPh3)4.

[0040] In one embodiment of the present invention, the palladium catalyst is Pd(PPh3)4.

[0041] Another embodiment of the present invention is a compound of formula (IX) [ka] or a salt thereof, wherein R 4 is CH2-NH-R 5 or NH2, R 5 is hydrogen, cyclopropyl, or -CH2- substituted with -CH2OCH3, -CHF2, -CF3, 3-pyridinyl or 4-pyridinyl.

[0042] In one embodiment of the invention, the compound of formula IX is selected from the group consisting of: [Table 3]

[0043] Another embodiment of the present invention is a compound of formula (IX) [ka] or a salt thereof, a) A compound of formula (V) [ka] with HC≡CC(CH3)2OH in the presence of a palladium catalyst, a base and optionally copper iodide to give a compound of formula (VI) [ka] To obtain b) reacting a compound of formula (VI) with a compound of formula (VII) R 8 -NH2 in the presence of a reducing agent, Formula (VIII) [ka] obtaining a compound of c) reacting either the compound of formula (VI) or the compound of formula (VIII) with KOH and K3PO4 to obtain the compound of formula (IX), During the ceremony, R 4 is CH2-NH-R 5 and R 5 is hydrogen, cyclopropyl, or -CH2- substituted with -CH2OCH3, -CHF2, -CF3, 3-pyridinyl or 4-pyridinyl, R 7 is C(O)H, and R 8 is cyclopropyl, or -CH2- substituted with -CH2OCH3, -CHF2, -CF3, 3-pyridinyl or 4-pyridinyl.

[0044] Another embodiment of the present invention is a compound of formula (IX) [ka] or a salt thereof, a) A compound of formula (V) [ka] with HC≡CC(CH3)2OH in the presence of a palladium catalyst, a base and optionally copper iodide to give a compound of formula (VI) [ka] To obtain b) reacting any of the compounds of formula (VI) with KOH and K3PO4 to obtain a compound of formula (IX), wherein R 4 and R 7 is NH2.

[0045] Another embodiment of the present invention is a compound of formula (III) [ka] or a salt thereof, In the formula, R 1 and R 2 are each independently hydrogen or C1-C4 alkyl; R 6 is -NHC(O)OC(CH3)3 or -OC(CH3)3.

[0046] In one embodiment of the present invention, R 1 and R 2 is CH3 and R 6 is -NHC(O)OC(CH3)3.

[0047] In one embodiment of the present invention, R 1 is CH3 and R 2 is hydrogen, and R 6 is -OC(CH3)3.

[0048] Another embodiment of the present invention is a compound of formula (IV) [ka] or a salt thereof, In the formula, R 1 and R 2 are each independently hydrogen or C1-C4 alkyl; R 6 is -NHC(O)OC(CH3)3 or -OC(CH3)3.

[0049] In one embodiment of the present invention, R 1 and R 2 is CH3 and R 6is -NHC(O)OC(CH3)3.

[0050] In one embodiment of the present invention, R 1 is CH3 and R 2 is hydrogen, and R 6 is -OC(CH3)3.

[0051] Another embodiment of the present invention is a compound of formula (VI) [ka] or a salt thereof, In the formula, R 7 is NH2.

[0052] Another embodiment of the present invention is a compound of formula (VIII) [ka] or a salt thereof, In the formula, R 8 is hydrogen, cyclopropyl, or -CH2- substituted with -CH2OCH3, -CHF2, -CF3, 3-pyridinyl or 4-pyridinyl.

[0053] In one embodiment of the present invention, the compound of formula VIII is selected from the group consisting of: [Table 4]

[0054] Hydroxamic Acids - Hydroxamic acids are a class of organic compounds with the functional group RC(O)N(OH)R', where R and R' are organic residues and CO is a carbonyl group. They are amides (RC(O)NHR') in which the NH center has an OH substitution. They are often used as metal chelating agents.

[0055] Sonogashira Coupling Reaction: This coupling of terminal alkynes with aryl or vinyl halides is carried out using a palladium catalyst and optionally a copper(I) cocatalyst (Rafael Chinchilla and Carmen Najera Chem.Rev.2007,107,3,874-922 Published: February 17, 2007 https: / / doi.org / 10.1021 / cr050992x).

[0056] A reducing agent is a substance that is susceptible to being oxidized and losing electrons, causing reduction. Examples are sodium borohydride (NaBH4), sodium cyanoborohydride, and sodium triacetoxyborohydride (Na(CH3CO2)BH).

[0057] A zero-valent palladium catalyst is one in which the palladium metal atom has a complete valence shell of electrons. Examples of such catalysts are Pd2(dba)3; Pd(tBu3P)2; Pd(Cy3P)2 or Pd(PPh3)4.

[0058] Further embodiments Embodiment 1. A compound of formula (I) [ka] or a salt thereof, comprising the steps of: Compound of formula (III) [ka] with a compound of formula (IV) [ka] and converting the compound of formula (IV) into a compound of formula (IX) [ka] or a salt thereof, Less than 2% of a compound of formula (XI) formed as a by-product [ka] obtaining a compound of formula (I) comprising During the ceremony, R 1 and R 2 are each independently hydrogen or C1-C4 alkyl; R 3 is NH2 or OH, R 4 is NH2 or CH2-NH-R 5 and R 5 is hydrogen, cyclopropyl, or -CH2- substituted with -CH2OCH3, -CHF2, -CF3, 3-pyridinyl or 4-pyridinyl, and R 6 is -NHC(O)OC(CH3)3 or -OC(CH3)3.

[0059] Embodiment 2. Compound of formula (III) [ka] is reacted with hydroxylamine in the presence of lithium hydroxide to give a compound of formula (IV) [ka] 2. The method of embodiment 1, comprising generating

[0060] Embodiment 3. Compound of formula (IV) [ka] with a compound of formula (IX) [ka] or its salt Coupling in the presence of a palladium catalyst, a base and optionally copper iodide to give a compound of formula (X) [ka] and then reacting the compound of formula (X) with The method according to any one of the preceding embodiments, comprising converting to a compound of formula (I) or a salt thereof.

[0061] Embodiment 4. Compound of formula (II) [ka] with 4 bromobenzoic acid to obtain a compound of formula (III) The method of any one of embodiments 1 to 3, comprising forming a compound of formula (III).

[0062] Embodiment 5. a) A compound of formula (II) [ka] is reacted with 4-bromobenzoic acid to give a compound of formula (III) [ka] The process of obtaining b) reacting a compound of formula (III) with hydroxylamine in the presence of lithium hydroxide to give a compound of formula (IV) [ka] A process for producing c) reacting a compound of formula (IV) with a compound of formula (IX) [ka] or its salt Reacting in the presence of a palladium catalyst, a base and optionally copper iodide to give a compound of formula (X) [ka] and d) reacting the compound of formula (X) with an acid to obtain a compound of formula (I) or a salt thereof, During the ceremony, R 1 and R 2are each independently hydrogen or C1-C4 alkyl; R 3 is NH2 or OH, R 4 is NH2 or CH2-NH-R 5 and R 5 is hydrogen, cyclopropyl, or -CH2- substituted with -CH2OCH3, -CHF2, -CF3, 3-pyridinyl or 4-pyridinyl, and R 6 is -NHC(O)OC(CH3)3 or -OC(CH3)3; The method according to any one of embodiments 1 to 4.

[0063] Embodiment 6. The method of any one of embodiments 3 to 5, wherein the palladium catalyst is Pd(PPh3)4.

[0064] Embodiment 7. The method of any one of embodiments 1-6, wherein the compound of formula (I) is selected from the group consisting of: [Table 5]

[0065] Embodiment 8. The method of any one of embodiments 1-7, wherein the compound of formula (I) is a hydrobromide salt, a dihydrobromide salt, a hydrochloride salt, or a dihydrochloride salt.

[0066] Embodiment 9. Compound of Formula (X) [ka] or a salt thereof, During the ceremony, R 1 and R 2 are each independently hydrogen or C1-C4 alkyl optionally substituted with NH2 or OH, R 4 is NH2 or CH2-NH-R 5 and R5 is hydrogen, cyclopropyl, or -CH2OCH3, -CHF2, -CF3, or 3-pyridinyl or 4-pyridinyl substituted -CH2-, and R 6 is -NHC(O)OC(CH3)3 or -OC(CH3)3.

[0067] Embodiment 10. The compound of embodiment 9, wherein the compound of formula X is selected from the group consisting of: [Table 6] Or its salt.

[0068] Embodiment 11. The compound of any one of embodiments 9-10, wherein the compound is a hydrobromide salt, a dihydrobromide salt, a hydrochloride salt, or a dihydrochloride salt.

[0069] Embodiment 12. A compound of formula (IX) [ka] or a salt thereof, Compound of formula (IV) [ka] in the presence of a palladium catalyst, a base and optionally copper iodide to obtain a compound of formula (X) and optionally converting it into a salt, During the ceremony, R 1 and R 2 are each independently hydrogen or C1-C4 alkyl optionally substituted with NH2 or OH, R 4 is NH2 or CH2-NH-R 5 and R 5 is hydrogen, cyclopropyl, or -CH2- substituted with -CH2OCH3, -CHF2, -CF3, 3-pyridinyl or 4-pyridinyl, and R6 is -NHC(O)OC(CH3)3 or -OC(CH3)3; A method for preparing a compound according to any one of embodiments 9 to 11.

[0070] Embodiment 13. The method of embodiment 12, wherein the palladium catalyst is Pd(PPh3)4.

[0071] Embodiment 14. A compound of formula (IX) [ka] or a salt thereof, wherein R 4 is CH2-NH-R 5 or NH2, R 5 is hydrogen, cyclopropyl, or -CH2- substituted with -CH2OCH3, -CHF2, -CF3, 3-pyridinyl or 4-pyridinyl.

[0072] Embodiment 15. The compound of embodiment 14, wherein the compound of formula IX is selected from the group consisting of: [Table 7]

[0073] Embodiment 16. A method for preparing a compound or salt thereof according to any one of embodiments 14 or 15, comprising: a) A compound of formula (V) [ka] with HC≡CC(CH3)2OH in the presence of a palladium catalyst, a base and optionally copper iodide to give a compound of formula (VI) [ka] To obtain b) reacting a compound of formula (VI) with a compound of formula (VII) R 8-NH2 in the presence of a reducing agent, Compound of formula (VIII) [ka] to get c) reacting either the compound of formula (VI) or the compound of formula (VIII) with KOH and K3PO4 to obtain the compound of formula (IX), During the ceremony, R 4 is CH2-NH-R 5 and R 5 is hydrogen, cyclopropyl, or -CH2- substituted with -CH2OCH3, -CHF2, -CF3, 3-pyridinyl or 4-pyridinyl, R 7 is C(O)H, R 8 is cyclopropyl, or -CH2- substituted with -CH2OCH3, -CHF2, -CF3, 3-pyridinyl or 4-pyridinyl.

[0074] Embodiment 17. A compound according to any one of embodiments 14 or 15. [ka] or a salt thereof, a) A compound of formula (V) [ka] with HC≡CC(CH3)2OH in the presence of a palladium catalyst, a base and optionally copper iodide to give a compound of formula (VI) [ka] to get b) reacting any of the compounds of formula (VI) with KOH and K3PO4 to obtain compounds of formula (IX), In the formula, R 4 and R 7is NH2.

[0075] Embodiment 18. Compound of formula (III) [ka] or a salt thereof, In the formula, R 1 and R 2 are each independently hydrogen or C1-C4 alkyl; R 6 is -NHC(O)OC(CH3)3 or -OC(CH3)3.

[0076] Embodiment 19. R 1 and R 2 is CH3, and R 6 is -NHC(O)OC(CH3)3.

[0077] Embodiment 20. R 1 is CH3 and R 2 is hydrogen, and R 6 is -OC(CH3)3.

[0078] Embodiment 21. A compound of formula (IV) [ka] or a salt thereof, In the formula, R 1 and R 2 are each independently hydrogen or C1-C4 alkyl, and R 6 is -NHC(O)OC(CH3)3 or -OC(CH3)3.

[0079] Embodiment 22. R 1 and R 2 is CH3, and R 6 The compound of embodiment 21, wherein is -NHC(O)OC(CH3)3.

[0080] Embodiment 23. R1 is CH3 and R 2 is hydrogen, and R 6 The compound of embodiment 21, wherein is -OC(CH3)3.

[0081] Embodiment 24. R 7 is NH2, Compound of formula (VI) [ka] Or its salt.

[0082] Embodiment 25. R 8 is hydrogen, cyclopropyl, or -CH2OCH3, -CHF2, -CF3, 3-pyridinyl or 4-pyridinyl substituted -CH2-; Compound of formula (VIII) [ka] Or its salt.

[0083] Embodiment 26. The compound of embodiment 25, wherein the compound of formula VIII is selected from the group consisting of: [Table 8]

[0084] [Example] HPLC method: Method A Agilent Technologies UHPLC / MSD 6130 B Series 1290, consisting of: Binary Pump G7120A with Degasser Well Plate Sampler G4226A Column oven G1316B Diode array detector G4212A Quadrupole LC / MS with mass detector G6130B ESI source Column: Waters XP, 2.1×50 mm Xbridge BEH C18 2.5μ, T=40° C.; Eluent: A: acetonitrile containing 0.05% (vol. / vol.) formic acid B: water containing 0.05% formic acid (vol. / vol.); Flow rate: 0.8mL / min; Gradient: 2–100% eluent A 1.2 min, 100% eluent A 0.5 min; Run time: 2.2 minutes; Detection: ESI / MS, positive and negative ions Scan: 100–1000 m / z; UV at 254 and 210 nm;

[0085] Method B Agilent Technologies UHPLC / MS 1260 Series, consisting of: Binary Pump G7120A with Degasser Well Plate Sampler G4226A Column oven G7116B Diode array detector G7117B Mass detector G6150B Quadrupole LC / MS with ESI jet stream source Column: Waters XP, 2.1×50 mm Xbridge BEH C18 2.5μ, T=40° C.; Eluent: A: acetonitrile containing 0.05% (vol. / vol.) formic acid B: water containing 0.05% formic acid (vol. / vol.); Flow rate: 0.8mL / min; Gradient: 2–100% eluent A 1.2 min, 100% eluent A 0.5 min; Run time: 2.2 minutes; Detection: ESI / MS, positive and negative ions Scan: 100–1000 m / z; UV at 254 and 210 nm;

[0086] Method C Agilent Technologies UHPLC / MS 1260 Series, consisting of: Binary Pump G4220A with Degasser Well Plate Sampler G4226A Column oven G7116B Diode array detector G4212A Mass detector G6130B Quadrupole LC / MS with ESI / APCI multimode source Column: Waters XP, 2.1×50 mm Xbridge BEH C18 2.5μ, T=40° C.; Eluent: A: acetonitrile containing 0.05% (vol. / vol.) formic acid B: water containing 0.05% formic acid (vol. / vol.); Flow rate: 0.8mL / min; Gradient: 2–100% eluent A 1.2 min, 100% eluent A 0.5 min; Run time: 2.2 minutes; Detection: ESI / MS, positive and negative ions Scan: 100–1000 m / z; UV at 254 and 210 nm;

[0087] Comparative Example 1: Preparation of (S)-N-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-((4-((cyclopropylamino)methyl)phenyl)ethynyl)benzamide [ka]

[0088] Methyl (S)-3-amino-2-(4-((4-((cyclopropylamino)methyl)phenyl)ethynyl)benzamido)-3-methylbutanoate hydrochloride (1 g, 2.19 mmol) was dissolved in methanol (10 mL). The resulting solution was cooled to 0° C. and 50% aqueous hydroxylamine (1.61 mL, 26.3 mmol) was added dropwise while maintaining the temperature below 2° C. Then lithium hydroxide monohydrate (0.28 g, 6.58 mmol) was added in portions while maintaining the temperature below 2° C. After 2 h reaction time, the reaction mixture was allowed to warm to ambient temperature and stirred for an additional 18 h. The reaction mixture was diluted with water (40 mL) and the volatiles were removed by evaporation under reduced pressure. The pH of the remaining aqueous layer was adjusted to pH 8.5 by addition of 1 M aqueous hydrochloric acid and the aqueous layer was extracted with a 2:1 mixture of dichloromethane and 2-propanol (2×50 mL). The organic layer was washed with brine (20 mL) and concentrated under reduced pressure to give the desired product as a yellow solid (775 mg, 1.70 mmol) in the presence of 8 area % of the corresponding carboxylic acid. [ka]

[0089] LC / MS (Method A): Rt=0.53 min, m / z 419 (desired product) and Rt=0.57 min, m / z 404 (carboxylic acid).

[0090] Comparative Example 2: Preparation of tert-butyl (S)-(3-(4-((4-((cyclopropylamino)methyl)phenyl)ethynyl)benzamido)-4-(hydroxyamino)-2-methyl-4-oxobutan-2-yl)carbamate [ka]

[0091] Methyl (S)-3((tert-butoxycarbonyl)-amino)-2-(4-((4-((cyclopropylamino)methyl)phenyl)ethynyl)benzamido)-3-methylbutanoate (0.50 g, 0.96 mmol) was dissolved in methanol (5 mL). The resulting solution was cooled to -5°C and 50% aqueous hydroxylamine (0.71 mL, 11.55 mmol) was added dropwise while keeping the temperature below -2°C. Lithium hydroxide monohydrate (0.081 g, 1.92 mmol) was added and after a reaction time of 15 min the reaction mixture was allowed to reach room temperature. After a reaction time of 19 h at room temperature, water (5 mL) was added and the volatiles were removed by evaporation under reduced pressure. The pH of the aqueous residue was adjusted to pH 9.5 by addition of 1N aqueous hydrochloric acid and the aqueous layer was extracted with methyl tert-butyl ether (2 x 20 mL). The combined organic layers were dried over sodium sulfate, filtered, and concentrated under reduced pressure to give the desired product as a pale yellow solid (500 mg, 0.86 mmol) in the presence of 14 area % of the corresponding carboxylic acid. [ka]

[0092] LC / MS (Method A): Rt=0.82 min, m / z 519 (desired product) and Rt=0.90 min, m / z 504 (carboxylic acid).

[0093] Preparation of compounds of formula (IX) [ka]

[0094] The compound of formula (IX) can be prepared according to the synthetic methods disclosed in Example 1. The compound of formula (IX) can be conveniently isolated as either the free base or the hydrochloride salt as disclosed in Examples 1-6.

[0095] [Example 1] Preparation of N-(4-ethynylbenzyl)cyclopropanamine hydrochloride [ka]

[0096] Step 1: Preparation of 4-(3-hydroxy-3-methylbut-1-yn-1-yl)benzaldehyde A jacketed glass reactor (2 L) was charged with substituted 4-bromobenzaldehyde (100 g, 540 mmol), tetrakis(triphenylphosphine)palladium(0) (3.12 g, 2.70 mmol) and copper(I) iodide (1.029 g, 5.40 mmol) and flushed with nitrogen. Dry tetrahydrofuran (1 L) was added and the resulting mixture was stirred at ambient temperature. After 15 minutes, triethylamine (151 mL, 1081 mmol) and 2-methylbut-3-yn-2-ol (53.9 ml, 540 mmol) were added sequentially. Upon addition of the alcohol, the temperature of the reaction mixture increased; however, the temperature of the mixture was maintained below 30° C. After the addition was complete, the reaction mixture was brought to reflux (approximately 62° C.). After 70 min reaction time, the temperature of the reaction mixture was lowered to 15° C. and the mixture was filtered through a fritted funnel filled with a thin layer of cellulose and celite. The filter cake was washed with ethyl acetate (about 750 mL) and dried under reduced pressure at 40° C. to obtain the desired compound. The volume of the mother liquor was reduced to about 2 volumes, followed by dilution of the concentrate with ethyl acetate (750 mL) and extraction of the organic layer with water (2×300 mL), allowing a second crop of the desired product to be isolated after concentrating the organic layer. The combined crop of the desired product (105 g, 530 mmol) was used in the next step without further purification.

[0097] 1 H NMR (300 MHz, d3-dimethylsulfoxide) δ (ppm): 10.0 (1H, s), 7.90 (2H, J = 8.3 Hz, bd), 7.60 (2H, J = 8.3 Hz, bd), 5.59 (1H, s), 1.49 (6H, s) LC / MS (Method B): Rt=0.95 min, m / z 230

[0098] Step 2: Preparation of 4-(4-((cyclopropylamino)methyl)phenyl)-2-methylbut-3-yn-2-ol A jacketed glass reactor (5 L) was charged with methanol (1750 mL), 4-(3-hydroxy-3-methylbut-1-yn-1-yl)benzaldehyde (105 g, 530 mmol) and cyclopropylamine (44.7 mL, 636 mmol) and the resulting mixture was stirred at ambient temperature for 3 h. The temperature of the reaction mixture was then lowered to 5°C, after which sodium borohydride (14.2 g, 371 mmol) was added in portions to maintain the temperature of the reaction mixture at 5-10°C. After the addition was complete, the reaction mixture was stirred at 5-10°C for 1 h and water (500 mL) was added while maintaining the temperature below 10°C. The reaction mixture was then filtered through a fritted funnel filled with a thin layer of cellulose and celite, and the reactor was rinsed twice with a mixture of water (60 mL) and methanol (210 mL) used to wash the wet cake. Aqueous hydrochloric acid was added to the filtrate while maintaining the temperature below 10° C. until a pH of 1 was reached. The resulting mixture was stirred for 30 minutes and the layers were allowed to settle. The aqueous layer was collected, diluted with toluene (1 L) and the pH was adjusted to pH 8.5 by adding aqueous sodium hydroxide. After stirring for 15 minutes, the layers were allowed to settle and the organic layer was collected. Sodium chloride (150 g) was added to the aqueous layer and toluene (400 mL) was added. The resulting mixture was stirred for 30 minutes and the layers were separated before combining the second organic layer with the first organic layer. The combined organic layers were taken on to the next step.

[0099] 1 H NMR (300 MHz, d3-dimethylsulfoxide) δ (ppm): 8.20 (1H, s), 7.33 (4H, s), 3.78 (2H, s), 2.14-2.07 (1H, m), 1.45 (6H, s), 0.42-0.37 (2H, m), 0.34-0.29 (2H, m) LC / MS (Method B): Rt=0.95 min, m / z 230

[0100] Step 3: Preparation of N-(4-ethynylbenzyl)cyclopropanamine hydrochloride A solution of 4-(4-((cyclopropylamino)methyl)phenyl)-2-methylbut-3-yn-2-ol (121 g, 527 mmol) in toluene (2500 mL) was charged to a jacketed glass reactor (5 L) and potassium hydroxide (30 g, 535 mmol) and tripotassium phosphate (112 g, 528 mmol) were added. The temperature was set to 85° C. and the reaction mixture was stirred at this temperature for 135 minutes. Heating was then stopped and the reaction mixture was allowed to reach room temperature before water (750 mL) was added. The resulting mixture was stirred for 30 minutes and the layers were allowed to settle. The aqueous layer was discarded and 1N aqueous sodium hydroxide solution (500 mL) was added. After stirring for 15 minutes, the layers were allowed to settle and the aqueous layer was discarded. The organic layer was then washed again with water (500 mL) and diluted with toluene (500 mL). A 5N solution of hydrochloric acid in 2-propanol (160 mL) was added under stirring while maintaining the temperature below 25° C. The reaction mixture was stirred at this temperature for 16 h. The resulting suspension was filtered and the wet cake was rinsed with ethyl acetate (500 mL) and methyl tert-butyl ether (500 mL). The rinsed wet cake was finally dried under reduced pressure at 35° C. to give the desired product (79.5 g, 380 mmol, 72% yield).

[0101] 1 H NMR (300 MHz, d3-dimethylsulfoxide) δ (ppm): 9.71 (2H, s), 7.61 (2H, J = 8.4 Hz, d), 7.53 (2H, J = 8.4 Hz, d), 4.30 (1H, s), 4.21 (2H, s), 2.66-2.56 (1H, m), 0.95-0.90 (2H, m), 0.74-0.67 (2H, m) LC / MS (Method B): Rt=1.01 min, m / z 172

[0102] [Example 2] Preparation of N-(4-ethynylbenzyl)-2-methoxyethan-1-amine hydrochloride [ka]

[0103] N-(4-ethynylbenzyl)-2-methoxyethan-1-amine hydrochloride was prepared using the appropriate amine following the general method described in Example 1. The desired product was isolated as a white solid (82% yield).

[0104] 1 H NMR (300MHz, d4-methanol) δ (ppm): 7.48-7.44 (2H, m), 7.41-7.38 (2H, m), 4.14 (2H, s), 3.57-3.54 (2H, m), 3.53 (1H, s), 3.31 (3H, s), 3.15-3.10 (2H, m). LC / MS (Method A): Rt=0.57 min, m / z 190

[0105] [Example 3] Preparation of N-(4-ethynylbenzyl)-1-(pyridin-4-yl)methanamine [ka]

[0106] Preparation of N-(4-ethynylbenzyl)-1-(pyridin-4-yl)methanamine was achieved following steps 1 and 2 of the general method described in Example 1 to yield 2-methyl-4-(4-(((pyridin-4-ylmethyl)amino)methyl)phenyl)but-3-yn-2-ol. Step 3 was carried out as follows:

[0107] Step 3: Preparation of N-(4-ethynylbenzyl)-1-(pyridin-4-yl)methanamine A solution of 2-methyl-4-(4-(((pyridin-4-ylmethyl)amino)methyl)phenyl)but-3-yn-2-ol (60 g, 213 mmol) in toluene (1300 mL) was charged to a jacketed glass reactor (3 L) and potassium hydroxide (12 g, 213 mmol) and tripotassium phosphate (45 g, 213 mmol) were added. The temperature was set to 100° C. and the reaction mixture was stirred at this temperature for 4 hours. Then, the heating was stopped and the reaction mixture was allowed to reach room temperature before water (350 mL) was added. The resulting mixture was stirred for 30 minutes and filtered. The layers were allowed to settle and the aqueous layer was discarded. The organic layer was washed successively with 1N aqueous sodium hydroxide solution (250 mL), water (2×150 mL) and brine (100 mL). The organic layer was concentrated under reduced pressure to finally give the desired product (37.9 g, 157 mmol, 74% yield).

[0108] 1 H NMR (300 MHz, d3-dimethylsulfoxide) δ (ppm): 8.49-8.47 (2H, m), 7.44-7.34 (6H, m), 4.14 (1H, s), 3.68 (4H, s), 2.90 (1H, s) LC / MS (Method A): Rt=0.49 min, m / z 223

[0109] [Example 4] Preparation of N-(4-ethynylbenzyl)-1-(pyridin-3-yl)methanamine [ka]

[0110] Preparation of N-(4-ethynylbenzyl)-1-(pyridin-3-yl)methanamine was accomplished following steps 1 and 2 of the general method described in Example 1 to yield 2-methyl-4-(4-(((pyridin-3-ylmethyl)amino)methyl)phenyl)but-3-yn-2-ol. Step 3 was carried out as follows:

[0111] Step 3: Preparation of N-(4-ethynylbenzyl)-1-(pyridin-3-yl)methanamine A solution of 2-methyl-4-(4-(((pyridin-3-ylmethyl)amino)methyl)phenyl)but-3-yn-2-ol (60 g, 213 mmol) in toluene (1.2 L) was charged to a jacketed glass reactor (3 L) and potassium hydroxide (12 g, 213 mmol) and tripotassium phosphate (45 g, 213 mmol) were added. The temperature was set to reflux and the reaction mixture was stirred at this temperature for 3.5 h. Heating was then stopped and the reaction mixture was allowed to reach room temperature before water (350 mL) was added. The resulting mixture was stirred for 30 min and filtered. The layers were allowed to settle and the aqueous layer was discarded. The organic layer was washed successively with 1N aqueous sodium hydroxide solution (250 mL), water (2×125 mL) and brine (100 mL). The organic layer was concentrated under reduced pressure to finally give the desired product (44 g, 198 mmol, 93% yield). HCl was added to the free base to make the compound easier to handle for analytical purposes.

[0112] From the corresponding hydrochloride salt: 1 H NMR (300MHz, d3-dimethylsulfoxide) δ (ppm): 10.28 (2H, bs), 9.07 (1H, J=1.5 Hz,bd), 8.89(1H,J=1.5,5.5Hz,dd), 8.66(1H,J=8.7Hz,bd), 8.00-7.96(1H, m), 7.63(2H,J=8.5Hz,d), 7.54(2H,J=8.5Hz,d), 4.38(2H,bs), 4.24(2H,bs). LC / MS (Method A): Rt=0.51 min, m / z 223

[0113] [Example 5] Preparation of N-(4-ethynylbenzyl)-2,2,2-trifluoroethan-1-amine hydrochloride [ka]

[0114] To a solution of 4-((trimethylsilyl)ethynyl)benzaldehyde (7.85 g, 37 mmol) in dry tetrahydrofuran (150 mL) was added 2,2,2-trifluoroethan-1-amine (2.92 mL, 37 mmol) and the reaction mixture was stirred at ambient temperature for 15 h. Sodium triacetoxyborohydride (39.5 g, 186 mmol) was then added in small portions to maintain the temperature of the reaction mixture below 30° C. The resulting suspension was stirred for 2.5 h after which complete conversion of the starting material was observed. With vigorous stirring, water (50 mL) was added slowly to control gas evolution. After gas evolution had ceased, more water (100 mL), potassium carbonate (41.2 g, 298 mmol) and methanol (200 mL) were added with vigorous stirring. Once complete conversion to the desired product was ensured, the volatiles were evaporated under reduced pressure and the reaction mixture was extracted with ethyl acetate (3×150 mL). The combined organic layers were washed with saturated aqueous sodium chloride (100 mL) and concentrated to approximately 60 mL. A 4N solution of hydrochloric acid in dioxane (11 mL, 44.0 mmol) was added dropwise and the reaction mixture was stirred for 60 min. The mixture was filtered and the wet cake was washed with ethyl acetate (50 mL), pentane (50 mL) and dried under reduced pressure at room temperature to give the desired product (5.99 g, 23 mmol, 62% yield).

[0115] 1 H NMR (300MHz, d3-methanol) δ (ppm): 7.55-7.48 (4H, m), 4.34 (2H, s), 4.02 (2H,J=9.1Hz,q), 3.60 (2H, s) LC / MS (Method A): Rt=0.98 min, m / z 214

[0116] [Example 6] Preparation of N-(4-ethynylbenzyl)-2,2,2-trifluoroethan-1-amine hydrochloride [ka]

[0117] The preparation of N-(4-ethynylbenzyl)-2,2,2-trifluoroethan-1-amine hydrochloride was accomplished following steps 1-3 of the general method described in Example 1.

[0118] 1 H NMR (300MHz, d3-methanol) δ(ppm): 7.62-7.52(4H, m), 6.33(1H,J=3.1,53.8Hz,tt), 4.35(2H,s), 3.67(1H,s), 3.60(2H,J=3.1,15.4Hz,td) LC / MS (Method A): Rt=0.56 min, m / z 196

[0119] Preparation of compounds of formula (IV) [ka]

[0120] [Example 7] Preparation of tert-butyl (S)-(3-(4-bromobenzamido)-4-(hydroxyamino)-2-methyl-4-oxobutan-2-yl)carbamate [ka]

[0121] Step 1: Preparation of methyl (S)-2-(4-bromobenzamido)-3-((tert-butoxycarbonyl)amino)-3-methylbutanoate A jacketed glass reactor (2 L) was charged with tetrahydrofuran (500 mL) and 4-bromobenzoic acid (74.2 g, 365 mmol). To the suspension, oxalyl chloride (34.3 mL, 384 mmol) and dimethylformamide (0.1 mL) were added successively under vigorous stirring at ambient temperature. A clear solution was obtained after 18 h reaction time, and complete conversion was ensured by reaction of a sample of the reaction mixture with butylamine. The reaction mixture was added within 15 min to a cooled (0 °C) solution of methyl (S)-2-amino-3-((tert-butoxycarbonyl)amino)-3-methylbutanoate (90 g, 365 mmol) and triethylamine (102 mL, 731 mmol) in tetrahydrofuran (360 mL). After 30 min reaction time, complete conversion was achieved. The reaction mixture was diluted with saturated aqueous sodium bicarbonate (1.5 L) and methyl tert-butyl ether (1.5 L) and stirred for 15 min. The layers were allowed to settle and the organic layer was collected. The aqueous layer was extracted with methyl tert-butyl ether (500 mL). The combined organic layers were concentrated under reduced pressure to give the desired product as an off-white solid (161 g, 357 mmol, 98% yield).

[0122] 1 H NMR (300MHz, d3-dimethylsulfoxide) δ(ppm): 10.92(1H,bs), 9.02(1H,s), 8.72(1H,J=8.3Hz,bd), 7.83(2H ,J=7.8Hz,d), 7.70(2H,J=7.8Hz,d), 6.70(1H,bs), 4.58(1H,J=8.3Hz,d), 1.36(9H,s), 1.33(6H,s) LC / MS (Method A): Rt=0.51 min, m / z 223

[0123] Step 2: Preparation of tert-butyl (S)-(3-(4-bromobenzamido)-4-(hydroxyamino)-2-methyl-4-oxobutan-2-yl)carbamate A jacketed glass reactor (5 L) was charged with methanol (800 mL) and methyl (S)-2-(4-bromobenzamido)-3-((tert-butoxycarbonyl)amino)-3-methylbutanoate (168 g, 356 mmol) and the resulting solution was cooled to 5° C. Hydroxylamine 50% aqueous solution (262 mL, 4.27 mol) was added within 5 min under stirring while maintaining the temperature of the mixture below 8° C. Lithium hydroxide monohydrate (60 g, 1.42 mol) was added in one portion and a temperature rise to 17° C. was observed. The reaction mixture was stirred at ambient temperature for 30 min after which complete conversion was observed (about 800 mL remained). The reaction mixture was diluted with water (300 mL) and the reaction mixture was concentrated under reduced pressure at 40° C. until the onset of precipitation was observed. The pH of the reaction mixture was adjusted to pH 9.0 by the addition of 1N aqueous hydrochloric acid (ca. 1.3 L) and methyl tert-butyl ether (2 L) was added. The resulting mixture was stirred for 15 min and the layers were allowed to settle. The organic layer was collected and the aqueous layer was extracted with methyl tert-butyl ether (1 L). The combined organic layers were washed with saturated aqueous sodium chloride (500 mL) and concentrated under reduced pressure. The resulting solid was suspended in methyl tert-butyl ether (800 mL) and the suspension was heated to reflux for 15 min and cooled to room temperature. The suspension was filtered and the wet cake was rinsed with diisopropyl ether (650 mL) and dried under reduced pressure at 40° C. to give the desired product as a white solid (117 g, 272 mmol, 76% yield).

[0124] 1 H NMR (300MHz, d3-dimethylsulfoxide) δ(ppm): 10.92(1H,bs), 9.02(1H,s), 8.72(1H,J=8.3Hz,bd), 7.83(2H ,J=7.8Hz,d), 7.70(2H,J=7.8Hz,d), 6.70(1H,bs), 4.58(1H,J=8.3Hz,d), 1.36(9H,s), 1.33(6H,s) LC / MS (Method A): Rt=1.00 min, m / z 341 / 339

[0125] [Example 8] Preparation of 4-bromo-N-((2S,3R)-3-(tert-butoxy)-1-(hydroxyamino)-1-oxobutan-2-yl)benzamide [ka]

[0126] Step 1: Preparation of methyl N-(4-bromobenzoyl)-O-(tert-butyl)-L-threoninate 4-Bromobenzoic acid (10 g, 49.7 mmol) is suspended in dry tetrahydrofuran (50 mL) at room temperature, and oxalyl chloride (4.57 mL, 52.2 mmol) and a few drops of DMF are added successively. The resulting reaction mixture turns into a clear solution, which is stirred at ambient temperature for 8 h. The reaction mixture is added within 15 min with stirring onto a cooled (0 °C) suspension of methyl O-(tert-butyl)-L-threoninate hydrochloride (11.23 g, 49.7 mmol) and triethylamine (20.8 mL, 149 mmol) in dry tetrahydrofuran (150 mL) and TEA (20.80 ml, 149 mmol). After 20 min of reaction time, the reaction mixture is concentrated under reduced pressure to about 100 mL. Saturated aqueous sodium bicarbonate solution (150 mL) and methyl tert-butyl ether (50 mL) are added and the mixture is stirred for 15 min. The layers are allowed to settle and the organic layer is collected. The aqueous layer was extracted with tert-butyl ether (50 mL) and the combined organic layers were washed with saturated aqueous sodium chloride and concentrated under reduced pressure to give the crude desired product, which was taken on to step 2 without further purification.

[0127] Step 2: Preparation of 4-bromo-N-((2S,3R)-3-(tert-butoxy)-1-(hydroxyamino)-1-oxobutan-2-yl)benzamide A jacketed glass reactor (1 L) was charged with methanol (200 mL) and the crude methyl N-(4-bromobenzoyl)-O-(tert-butyl)-L-threoninate (47.2 mmol) obtained in step 1. The resulting solution was cooled to 5° C. and 50% aqueous hydroxylamine (35 mL, 566 mmol) was added slowly followed by lithium hydroxide monohydrate (7.9 g, 189 mmol). The reaction mixture was vigorously stirred at ambient temperature until a white precipitate formed (approximately 30 min reaction time). The reaction mixture was diluted with water (250 mL) and concentrated under reduced pressure (approximately 100 mL). The pH of the mixture was adjusted to pH 9.0 by the addition of 1 M aqueous hydrochloric acid. The resulting suspension was extracted with methyl tert-butyl ether (500 mL and 2×100 mL). The combined organic layers were washed with saturated aqueous sodium chloride (100 ml) and concentrated under reduced pressure to give the desired product as an off-white solid (10.9 g, 29 mmol, 62% yield).

[0128] 1 H NMR(300MHz,d3-dimethylsulfoxide)δ(ppm):10.66(1H,bs), 8.94(1H,s), 8.13(1H,J=9.0Hz,bd), 7.84(2H,J=8.4Hz,d), 7 .69(2H,J=8.4Hz,d), 4.35(1H,J=5.5,9.0Hz,dd), 3.96(1H,J=5.5,6.3Hz,qd), 1.12(9H,s), 1.08(6H,J=6.3Hz,d). LC / MS (Method A): Rt=0.94 min, m / z 284 / 282

[0129] Preparation of compounds of formula (X) [ka]

[0130] [Example 9] Preparation of tert-butyl (S)-(3-(4-((4-((cyclopropylamino)methyl)phenyl)ethynyl)benzamido)-4-(hydroxyamino)-2-methyl-4-oxobutan-2-yl)carbamate [ka]

[0131] A jacketed glass reactor (2 L) was charged with anhydrous dimethylsulfoxide (1.2 L). The solvent was degassed by three vacuum / nitrogen purging cycles and tert-butyl (S)-(3-(4-bromobenzamido)-4-(hydroxyamino)-2-methyl-4-oxobutan-2-yl)carbamate (117 g, 272 mmol), N-(4-ethynylbenzyl)cyclopropanamine hydrochloride (50.8 g, 245 mmol), tetrakis(triphenylphosphine)palladium(0) (15.7 g, 13.6 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (143 mL, 952 mmol) were added. The temperature was raised to 70° C. and the reaction mixture was stirred at this temperature for 5 h. Heating was stopped and the temperature was allowed to reach room temperature. The reaction mixture was transferred to a larger reactor (20 L) and ethyl acetate (6 L) and 0.5 N aqueous hydrochloric acid (6 L) were added. The mixture was stirred for 15 min and the layers were allowed to settle. The aqueous layer was collected and the organic layer was extracted with 0.5 N aqueous hydrochloric acid (1.2 L). The pH of the combined aqueous layers was set to pH 6.0 by addition of saturated aqueous sodium carbonate (ca. 0.5 L) and the combined aqueous layers were extracted with ethyl acetate (6 L and 1.2 L). The combined organic layers were back extracted with saturated aqueous sodium bicarbonate (1.2 L), washed with saturated aqueous sodium chloride (1.2 L) and concentrated under reduced pressure to give the desired product as a pale yellow solid (118.4 g, 225 mmol, 92% yield).

[0132] 1H NMR(300MHz,d3-dimethylsulfoxide)δ(ppm):7.92(2H,J=8.3Hz,bd),7.64(2H,J=8.3Hz,bd),),7.54(2H,J=8.3Hz,bd),),7.41(2H,J=8.3 Hz,bd),4.72(1H,s),3.85(2H,s),2.18-2.14(1H,m),1.50(3H,s),1.47(9H,s),1.43(3H,s),0.52-0.49(2H,m),0.43-0.41(2H,m) LC / MS (Method A): Rt=0.79 min, m / z 521

[0133] [Example 10] Preparation of tert-butyl (S)-(4-(hydroxyamino)-3-(4-((4-(((2-methoxyethyl)amino)methyl)phenyl)ethynyl)benzamido)-2-methyl-4-oxobutan-2-yl)carbamate [ka]

[0134] A jacketed glass reactor (1 L) was charged with anhydrous dimethylsulfoxide (210 mL), tert-butyl (S)-(3-(4-bromobenzamido)-4-(hydroxyamino)-2-methyl-4-oxobutan-2-yl)carbamate (20.5 g, 47.6 mmol), N-(4-ethynylbenzyl)-2-methoxyethan-1-amine hydrochloride (9.68 g, 42.9 mmol), tetrakis(triphenylphosphine)palladium(0) (2.75 g, 2.4 mmol), copper(I) iodide (0.90 g, 4.8 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (25.1 ml, 167 mmol). The temperature was raised to 70° C. and the reaction mixture was stirred at this temperature for 1 h. Heating was discontinued and the reaction mixture was allowed to cool to ambient temperature. The mixture was transferred to a larger reactor (3 L) and ethyl acetate (800 mL) and 0.5 N aqueous hydrochloric acid (800 mL) were added. The mixture was stirred for 15 min and the layers were allowed to settle. The aqueous layer was collected and the organic layer was extracted with 0.5 N aqueous hydrochloric acid (400 mL). The combined aqueous layers were washed with ethyl acetate (200 mL) and the pH was adjusted to pH 6 by the addition of saturated aqueous sodium carbonate. The aqueous layer was extracted with ethyl acetate (2×600 mL), washed with saturated aqueous sodium chloride (200 mL) and concentrated under reduced pressure to give a grey solid. Purification by column chromatography on silica gel (eluent dichloromethane:methanol 90:10) afforded the desired product as a beige solid (18.8 g, 34.8 mmol, 81% yield). LC / MS (Method A): Rt=0.74 min, m / z 539

[0135] [Example 11] Preparation of tert-butyl (S)-(4-(hydroxyamino)-2-methyl-4-oxo-3-(4-((4-(((pyridin-4-ylmethyl)amino)methyl)phenyl)ethynyl)benzamido)butan-2-yl)carbamate [ka]

[0136] A jacketed glass reactor (500 mL) was charged with anhydrous degassed dimethylsulfoxide (150 mL), tert-butyl (S)-(3-(4-bromobenzamido)-4-(hydroxyamino)-2-methyl-4-oxobutan-2-yl)carbamate (28.5 g, 66 mmol), N-(4-ethynylbenzyl)-1-(pyridin-4-yl)methanamine (15.5 g, 64 mmol), tetrakis(triphenylphosphine)palladium(0) (3.83 g, 3.3 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (34.9 mL, 232 mmol). The temperature was raised to 50 °C and copper(I) iodide (1.26 g, 6.6 mmol) was added portionwise within 10 min under vigorous stirring. After the addition was complete, the temperature was set to 70° C. and the reaction mixture was stirred at this temperature for 30 min and allowed to cool to ambient temperature. The reaction mixture was poured into water (800 mL) with stirring and the precipitate formed was filtered. Ethyl acetate (800 mL) was added to the filtrate and the resulting mixture was stirred for 15 min. The layers were allowed to settle and the organic layer was collected. The aqueous layer was extracted with ethyl acetate (2×100 mL) and the combined organic layers were washed with saturated aqueous sodium chloride solution (100 mL) and concentrated under reduced pressure. Purification by column chromatography on silica gel (eluent ethyl acetate) afforded the desired product as a beige solid (22.7 g, 36.0 mmol, 56% yield).

[0137] 1 H NMR (300 MHz, d3-dimethyl sulfoxide) δ (ppm): 10.92 (1H, bs), 9.03 (1H, s), 8.73 (1H, J = 9.0 Hz, bd), 8.50 (2H, J = 5.9 Hz, bd), 7.93 (2H, J = 8.2 Hz, bd), 7.55 (2H, J = 8.2 Hz, bd), 7 .43(2H,J=8.2Hz,bd), 7.38(2H,J=5.9Hz,bd), 6.73(1H,s), 4.60(1H,J=8.9Hz,bd) , 3.72 (4H, m), 3.34 (1H, m), 2.55 (3H, s), 1.37 (9H, bs), 1.34 (3H, bs), 1.33 (3H, bs) LC / MS (Method A): Rt=0.70 min, m / z 572

[0138] [Example 12] Preparation of tert-butyl (S)-(4-(hydroxyamino)-2-methyl-4-oxo-3-(4-((4-(((pyridin-3-ylmethyl)amino)methyl)phenyl)ethynyl)benzamido)butan-2-yl)carbamate [ka]

[0139] A jacketed glass reactor (500 mL) was charged with anhydrous degassed dimethylsulfoxide (150 mL), tert-butyl (S)-(3-(4-bromobenzamido)-4-(hydroxyamino)-2-methyl-4-oxobutan-2-yl)carbamate (29.5 g, 68.6 mmol), N-(4-ethynylbenzyl)-1-(pyridin-3-yl)methanamine (14.8 g, 66.5 mmol), tetrakis(triphenylphosphine)palladium(0) (3.96 g, 3.43 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (36.2 mL, 240 mmol). The temperature of the resulting mixture was set to 50° C. and copper(I) iodide (1.31 g, 6.86 mmol) was added portionwise with stirring. After 40 min reaction time, complete conversion was observed and the reaction mixture was allowed to reach room temperature. The reaction mixture was poured into water (500 mL) with stirring and the pH was set to neutral by addition of 3N aqueous hydrochloric acid (ca. 55 mL). The formed precipitate was filtered, ethyl acetate (500 mL) was added to the filtrate and the mixture was stirred for 15 min. The layers were allowed to settle and the organic layer was collected. The aqueous layer was extracted with ethyl acetate (2×100 mL) and the combined organic layers were washed with saturated aqueous sodium chloride solution (100 mL) and concentrated under reduced pressure to give the desired product (36 g, 59.8 mmol, 90% yield).

[0140] 1H NMR (300MHz, d3-methanol) δ (ppm): 8.55 (1H, bs), 8.48 (1H, bs), 7.93-7.87 (3H, m), 7.64 (2H, J=8.1Hz, bd), 7. 55(2H,J=8.1Hz,bd), 7.46-7.40(3H,m), 4.72(1H,s), 3.83(4H,bs), 1.50(3H,s), 1.47(9H,s), 1.44(3H,s) LC / MS (Method A): Rt=0.72 min, m / z 572

[0141] [Example 13] Preparation of tert-butyl (S)-(3-(4-((4-(((2,2-difluoroethyl)amino)methyl)phenyl)ethynyl)benzamido)-4-(hydroxyamino)-2-methyl-4-oxobutan-2-yl)carbamate [ka]

[0142] The preparation of tert-butyl (S)-(3-(4-((4-(((2,2-difluoroethyl)amino)methyl)phenyl)ethynyl)benzamido)-4-(hydroxyamino)-2-methyl-4-oxobutan-2-yl)carbamate was accomplished by following the general method described in Example 9.

[0143] 1 H NMR (300MHz, d3-methanol) δ (ppm): 8.55 (1H, bs), 8.48 (1H, bs), 7.93-7.87 (3H, m), 7.64 (2H, J=8.1Hz, bd), 7. 55(2H,J=8.1Hz,bd), 7.46-7.40(3H,m), 4.72(1H,s), 3.83(4H,bs), 1.50(3H,s), 1.47(9H,s), 1.44(3H,s) LC / MS (Method A): Rt=0.75 min, m / z 545

[0144] [Example 14] Preparation of N-((2S,3R)-3-(tert-butoxy)-1-(hydroxyamino)-1-oxobutan-2-yl)-4-((4-(((2,2,2-trifluoroethyl)amino)methyl)phenyl)ethynyl)benzamide [ka]

[0145] The preparation of N-((2S,3R)-3-(tert-butoxy)-1-(hydroxyamino)-1-oxobutan-2-yl)-4-((4-(((2,2,2-trifluoroethyl)amino)methyl)phenyl)ethynyl)benzamide was accomplished following the general method described in Example 9. LC / MS (Method A): Rt=1.07 min, m / z 506

[0146] Preparation of Compounds of Formula (I) [ka]

[0147] [Example 15] Preparation of (S)-N-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-((4-((cyclopropylamino)methyl)phenyl)ethynyl)benzamide dihydrochloride [ka]

[0148] A jacketed glass reactor (1 L) was charged with acetonitrile (300 mL), water (50 mL) and tert-butyl (S)-(3-(4-((4-((cyclopropylamino)methyl)phenyl)ethynyl)benzamido)-4-(hydroxyamino)-2-methyl-4-oxobutan-2-yl)carbamate (90 g, 171 mmol). 12N aqueous hydrochloric acid (141 mL, 1.71 mol) was added at 25° C. within 5 min and a temperature increase to 33° C. was observed. After 3 h reaction time, complete conversion was achieved and the reaction mixture was added to acetone (4.5 L) at about 50° C. with vigorous stirring within 20 min. A suspension was obtained and heated to reflux for 10 min, after which the temperature was cooled to 25° C. and stirring was continued for 15 h. The precipitate was filtered off, washed with acetone (100 mL), and dried under reduced pressure at 40° C. to give the desired product as a pale yellow solid (73.7 g, 147 mmol, 86% yield).

[0149] 1 H NMR (300MHz, d3-dimethylsulfoxide) δ(ppm): 11.29(1H,s), 9.89(1H,bs), 9.24(1H,bs), 8.86(1H,J=9.3Hz,bd), 8.38(3H,bs), 8.10(2H,J=8.4Hz,bd ), 7.71-7.62(6H, m), 4.70(1H,J=9.3Hz,bd), 4.28-4.19(2H, m), 2.62( 1H, bs), 1.38 (3H, s), 1.36 (3H, s), 0.99-0.94 (2H, m), 0.74-0.67 (2H, m) LC / MS (Method A): Rt=0.53 min, m / z 421

[0150] [Example 16] Preparation of N-((2S,3R)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl)-4-((4-(((2,2,2-trifluoroethyl)amino)methyl)phenyl)ethynyl)benzamide [ka]

[0151] Aqueous 12N hydrochloric acid (10 mL, 120 mmol) was added dropwise to a stirred suspension of N-((2S,3R)-3-(tert-butoxy)-1-(hydroxyamino)-1-oxobutan-2-yl)-4-((4-(((2,2,2-trifluoroethyl)amino)methyl)phenyl)ethynyl)benzamide (3.09 g, 6.11 mmol) in acetonitrile (30 mL). The suspended solids dissolved and complete conversion was observed after stirring the resulting solution at ambient temperature for 30 min. The reaction mixture was diluted with water (100 mL) and the pH was adjusted to 8-9 by addition of saturated aqueous sodium bicarbonate solution and ethyl acetate (250 mL) was added. The resulting mixture was stirred for 15 min and the layers were allowed to settle. The organic layer was collected and the aqueous layer was extracted with ethyl acetate (250 mL). The combined organic layers were washed with saturated aqueous sodium bicarbonate (100 mL), aqueous sodium chloride (100 mL), brine and concentrated under reduced pressure. The crude product obtained was purified by recrystallization from ethyl acetate (ca. 100 mL), followed by washing the wet cake with methyl tert-butyl ether (20 mL) and drying under reduced pressure at 40° C. The desired product was obtained as an off-white solid (2.14 g, 4.76 mmol, 78% yield).

[0152] 1 H NMR (300MHz, d3-dimethylsulfoxide) δ(ppm): 10.70(1H,bs), 8.87(1H,bs), 8.16(1H,J= 8.7Hz,d), 7.96(2H,J=8.3Hz,d), 7.66(2H,J=8.3Hz,d), 7.56(2H,J=8.3Hz,d), 7. 42(2H,J=8.3Hz,d), 4.28(1H,J=5.5,8.3Hz,dd), 4.04(1H,J=5.5,6.9Hz,qd),3. 83(2H,J=6.9Hz,bd), 3.24-3.18(2H,m), 3.04-2.99(2H,m), 1.10(3H,J=6.3Hz,d) LC / MS (Method A): Rt=0.80 min, m / z 450

[0153] [Example 17] Preparation of (S)-N-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-((4-(((2-methoxyethyl)amino)methyl)phenyl)ethynyl)benzamide dihydrochloride [ka]

[0154] A 12N aqueous solution of hydrochloric acid (55 mL, 666 mmol) was added to a stirred solution of tert-butyl (S)-(4-(hydroxyamino)-3-(4-((4-(((2-methoxyethyl)amino)methyl)phenyl)ethynyl)benzamido)-2-methyl-4-oxobutan-2-yl)carbamate (20 g, 33 mmol) in a mixture of acetonitrile (180 mL) and water (20 mL) at ambient temperature within 5 min. After 3 h reaction time, complete conversion was observed. Volatiles were removed by distillation under reduced pressure and the resulting residue was diluted in dioxane (200 mL) and lyophilized to give the desired product as a pale yellow solid (20.8 g, 40 mmol, quantitative).

[0155] 1 H NMR(300MHz,d3-dimethylsulfoxide)δ(ppm):11.27(1H,s),9.51(2H,bs),8.82(1H,J=9.0Hz,bd),8.30(3H,bs),8.09(2H,J=8.4Hz,d),7.70-7 .66(6H,m),4.70(1H,J=9.0Hz,d),4.21-4.18(2H,m),3.65(2H,J=5.1Hz,bt),3.30(3H,s),3.11-3.03(2H,m),1.37(3H,s),1.35(3H,s) LC / MS (Method A): Rt=0.51 min, m / z 439

[0156] [Example 18] Preparation of (S)-N-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-((4-(((2,2-difluoroethyl)amino)methyl)phenyl)ethynyl)benzamide [ka]

[0157] The preparation of (S)—N-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-((4-(((2,2-difluoroethyl)amino)methyl)phenyl)ethynyl)benzamide was accomplished following the general method described in Example 15.

[0158] 1 H NMR(300MHz,d3-methanol)δ(ppm):7.90(2H,J=6.3Hz,d),7.63(2H,J=6.3Hz,d),7.54(2H,J=6.2Hz,d),7.40(2H,J=6.2H z,d),5.93(1H,J=3.2,40.8Hz,tt),4.48(1H,s),3.86(2H,s),2.92(2H,J=3.2,11.6Hz,td),1.31(3H,s),1.22(3H,s) LC-MS: (Method C): Rt=7.66 min, m / z 445

[0159] [Example 19] Preparation of (S)-N-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-((4-(((2,2,2-trifluoroethyl)amino)methyl)phenyl)ethynyl)benzamide [ka]

[0160] The preparation of (S)—N-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-((4-(((2,2,2-trifluoroethyl)amino)methyl)phenyl)ethynyl)benzamide was accomplished following the general method described in Example 15.

[0161] 1H NMR(300MHz,d3-メタノール)δ(ppm):7.88(2H,J=8.1Hz,d),7.59(2H,J=8.1Hz,d),7.51(2H,J=8.1Hz,d ),7.38(2H,J=8.1Hz,d),4.50(1H,s),3.87(2H,s),3.18(2H,J=9.9Hz,q),1.31(3H,s),1.23(3H,s) LC-MS: (Method C): Rt=8.47min, m / z 463.

Claims

1. Compounds of formula (I) [Formula 1] or a salt thereof, comprising the steps of: Compound of formula (III) [chemical 2] with a compound of formula (IV) [C3] and converting said compound of formula (IV) into a compound of formula (IX) [C4] or a salt thereof, to produce less than 2% of a compound of formula (XI) as a by-product. [C5] obtaining a compound of formula (I) comprising During the ceremony, R 1 and R 2 are each independently hydrogen or C 1 ~C 4 is alkyl, R 3 NH 2 or OH, R 4 NH 2 or CH 2 -NH-R 5 and R 5 is hydrogen, cyclopropyl, or -CH 2 OCH 3 , -CHF 2 , -CF 3 , 3-pyridinyl or 4-pyridinyl substituted —CH 2 - and R 6 is -NHC(O)OC(CH 3 ) 3 Or -OC(CH 3 ) 3 That is, method.

2. The compound of formula (III) [C6] with hydroxylamine in the presence of lithium hydroxide to obtain the compound of formula (IV) [C7] The method of claim 1 , comprising the step of generating

3. The compound of formula (IV) [C8] with a compound of formula (IX) [C9] or its salt Coupling in the presence of a palladium catalyst, a base and optionally copper iodide to give a compound of formula (X) [C10] and then reacting the compound of formula (X) with converting said compound of formula (I) or a salt thereof; The method according to any one of claims 1 to 2, comprising:

4. Compound of formula (II) [C11] with 4 bromobenzoic acid to give a compound of formula (III) The method of any one of claims 1 to 3, comprising forming the compound of formula (III).

5. a) a compound of formula (II) [C12] with 4-bromobenzoic acid to give a compound of formula (III) [C13] The process of obtaining b) reacting the compound of formula (III) with hydroxylamine in the presence of lithium hydroxide to give a compound of formula (IV) [C14] A process for producing c) reacting the compound of formula (IV) with a compound of formula (IX) [C15] or its salt In the presence of a palladium catalyst, a base and optionally copper iodide, a compound of formula (X) is obtained. [C16] and d) reacting said compound of formula (X) with an acid to obtain said compound of formula (I) or a salt thereof, During the ceremony, R 1 and R 2 are each independently hydrogen or C 1 ~C 4 is alkyl, R 3 But NH 2 or OH, R 4 But NH 2 or CH 2 -NH-R 5 and R 5 is hydrogen, cyclopropyl, or —CH 2 OCH 3 , -CHF 2 , -CF 3 , 3-pyridinyl or 4-pyridinyl substituted —CH 2 - and R 6 is -NHC(O)OC(CH 3 ) 3 Or -OC(CH 3 ) 3 That is, The method according to any one of claims 1 to 4.

6. The palladium catalyst is Pd(PPh 3 ) 4 The method according to any one of claims 3 to 5, wherein

7. The method according to any one of claims 1 to 6, wherein the compound of formula (I) is selected from the group consisting of: [Table 1]

8. The method according to any one of claims 1 to 7, wherein the compound of formula (I) is a hydrobromide salt, a dihydrobromide salt, a hydrochloride salt or a dihydrochloride salt.

9. Compound of formula (X) [C17] or a salt thereof; During the ceremony, R 1 and R 2 are each independently hydrogen or NH 2 or C optionally substituted with OH 1 ~C 4 is alkyl, R 4 NH 2 or CH 2 -NH-R 5 and R 5 is hydrogen, cyclopropyl, or -CH 2 OCH 3 , -CHF 2 , -CF 3 or 3-pyridinyl or 4-pyridinyl substituted —CH 2 - and R 6 is -NHC(O)OC(CH 3 ) 3 Or -OC(CH 3 ) 3 It is.

10. 10. The compound of claim 9, wherein the compound of formula X is selected from the group consisting of: [Table 2] Or its salt.

11. The compound according to any one of claims 9 to 10, wherein the compound is a hydrobromide salt, a dihydrobromide salt, a hydrochloride salt or a dihydrochloride salt.

12. A method for preparing a compound according to any one of claims 9 to 11, comprising the steps of: Compound of formula (IX) [C18] or a salt thereof, Compound of formula (IV) [C19] in the presence of a palladium catalyst, a base and optionally copper iodide to obtain a compound of formula (X) and optionally converting it into a salt, During the ceremony, R 1 and R 2 are each independently hydrogen or NH 2 or C optionally substituted with OH 1 ~C 4 is alkyl, R 4 But NH 2 or CH 2 -NH-R 5 and R 5 is hydrogen, cyclopropyl, or —CH 2 OCH 3 , -CHF 2 , -CF 3 , 3-pyridinyl or 4-pyridinyl substituted —CH 2 - and R 6 is -NHC(O)OC(CH 3 ) 3 Or -OC(CH 3 ) 3 That is, the method.

13. The palladium catalyst is Pd(PPh 3 ) 4 The method of claim 12, wherein

14. Compound of formula (IX) [C20] or a salt thereof; During the ceremony, R 4But, CH 2 -NH-R 5 or NH 2 and R 5 is hydrogen, cyclopropyl, or —CH 2 OCH 3 , -CHF 2 , -CF 3 , 3-pyridinyl or 4-pyridinyl substituted —CH 2 -It is.

15. The compound of claim 14, wherein the compound of formula IX is selected from the group consisting of: [Table 3]

Citation Information

Patent Citations

  • Compound acting as antibiotics

    EP3750881A1

  • JP1973001978U

  • Compounds for the treatment of bovine or swine respiratory disease

    WO2018115432A2